CD40 and myeloid sarcoma: Mechanistically, the immunological cascade in MS commences with CD4+ T cell activation, which leads to increased CD40L expression on T cells and facilitates co-stimulation of APCs via CD40, culminating in the production of IL-12 and IL-18, which stimulates T cells to produce IFN-γ [197].